{
  "id": "sequoia:pendulum-therapeutics",
  "sequoia_id": null,
  "name": "Pendulum",
  "slug": "pendulum-therapeutics",
  "description": "Pendulum develops novel interventions that target the human microbiome to improve the lives of patients suffering from a variety of diseases. Its targeted formulations, made with natural bacterial strains, help rebalance the microbiome, which restores peopleâ€™s health.",
  "website": "https://pendulum.co/",
  "socials": {
    "twitter": "https://www.twitter.com/Pendulum_Co",
    "linkedin": "https://www.linkedin.com/company/pendulumco/?viewAsMember=true"
  },
  "categories": [
    "healthcare"
  ],
  "current_stage": null,
  "first_partnered_year": 2017,
  "partners": [
    "jess-lee",
    "roelof-botha",
    "sonya-huang"
  ],
  "primary_partner": "jess-lee",
  "milestones": {
    "founded_year": 2012,
    "partnered_year": 2017,
    "ipo_year": null,
    "acquired_year": null
  },
  "team": [
    {
      "name": "James Bullard",
      "role": null
    },
    {
      "name": "Colleen Cutcliffe",
      "role": null
    },
    {
      "name": "John Eid",
      "role": null
    }
  ],
  "why_partnered": null,
  "source_urls": {
    "directory": "https://sequoiacap.com/our-companies/",
    "profile": "https://sequoiacap.com/companies/pendulum-therapeutics/"
  }
}
